Adjuvants for a New Generation of Vaccines
Subunit antigens of viruses and other infectious agents in their natural configuration can be produced by recombinant DNA technology. To elicit protective immunity such antigens have to be administered with adjuvants that elicit cell-mediated immunity, including genetically restricted cytotoxicity,...
Saved in:
| Main Authors: | Anthony C Allison, Noelene E Byars |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1992-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/1992/342364 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovative adjuvant strategies for next-generation pertussis vaccines
by: Ge Yu, et al.
Published: (2025-12-01) -
Development of a vaccine adjuvant based on squalene and study of its adjuvant properties
by: E. A. Volosnikova, et al.
Published: (2023-06-01) -
Nano/Micro-Enabled Modification and Innovation of Conventional Adjuvants for Next-Generation Vaccines
by: Xingchi Liu, et al.
Published: (2025-05-01) -
Freund’s adjuvant is a classic of vaccine adjuvants and the basis of experimental immunology
by: F.V. Hladkykh
Published: (2024-11-01) -
Carbohydrate-Based Adjuvants for Vaccine Production
by: S. S. Kurashova, et al.
Published: (2018-06-01)